BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19460128)

  • 1. Serum levels of Midkine in children and adolescents without malignant disease.
    Lucas S; Henze G; Schnabel D; Barthlen W; Sakuma S; Kurtz A; Driever PH
    Pediatr Int; 2010 Feb; 52(1):75-9. PubMed ID: 19460128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased midkine serum levels in pediatric embryonal tumor patients.
    Lucas S; Reindl T; Henze G; Kurtz A; Sakuma S; Driever PH
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):713-7. PubMed ID: 19727009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased midkine levels in sera from patients with Alzheimer's disease.
    Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum midkine levels are increased in patients with various types of carcinomas.
    Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
    Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids.
    Soulié P; Héroult M; Bernard I; Kerros ME; Milhiet PE; Delbé J; Barritault D; Caruelle D; Courty J
    J Immunoassay Immunochem; 2002; 23(1):33-48. PubMed ID: 11848100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum midkine concentrations and gastric cancer.
    Obata Y; Kikuchi S; Lin Y; Yagyu K; Muramatsu T; Kumai H;
    Cancer Sci; 2005 Jan; 96(1):54-6. PubMed ID: 15649256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two clusters of serum midkine levels in drug-naive patients with schizophrenia.
    Shimizu E; Hashimoto K; Salama RH; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Nakazato M; Kumakiri C; Okada S; Muramatsu H; Muramatsu T; Iyo M
    Neurosci Lett; 2003 Jun; 344(2):95-8. PubMed ID: 12782336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level.
    Çetin Sorkun H; Akbulut M; Enli Y; Tepeli E; Özkan S; Erdem E
    Turk J Med Sci; 2016 Jan; 46(1):219-27. PubMed ID: 27511357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients.
    Soulié P; Héroult M; Bernard-Pierrot I; Caruelle D; Oglobine J; Barritault D; Courty J
    Cancer Detect Prev; 2004; 28(5):319-24. PubMed ID: 15542254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Serum Midkine in Patients With Acute Pancreatitis.
    Li Y; Lu Y; Shen J; Xu C
    Am J Med Sci; 2017 Dec; 354(6):548-552. PubMed ID: 29208250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas.
    Muramatsu H; Song XJ; Koide N; Hada H; Tsuji T; Kadomatsu K; Inui T; Kimura T; Sakakibara S; Muramatsu T
    J Biochem; 1996 Jun; 119(6):1171-5. PubMed ID: 8827454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre-analytical problems on assay conditions for blood midkine].
    Hando A; Takesima S; Takahama M; Itoh S; Yokoo T; Kasai M; Yamashita Y; Takashima M; Fujita K; Shibata A; Imai T; Taketomi M; Okabe H
    Rinsho Byori; 2008 Mar; 56(3):221-7. PubMed ID: 18411806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of urinary midkine in various cancer patients.
    Ikematsu S; Okamoto K; Yoshida Y; Oda M; Sugano-Nagano H; Ashida K; Kumai H; Kadomatsu K; Muramatsu H; Takashi Muramatsu ; Sakuma S
    Biochem Biophys Res Commun; 2003 Jun; 306(2):329-32. PubMed ID: 12804566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
    Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes].
    Głowińska B; Urban M
    Wiad Lek; 2003; 56(3-4):109-16. PubMed ID: 12923954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis.
    Maruyama K; Muramatsu H; Ishiguro N; Muramatsu T
    Arthritis Rheum; 2004 May; 50(5):1420-9. PubMed ID: 15146411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
    Shaygannejad V; Montazeri S; Jamshidian A; Tahani S; Gharagozloo M; Ashtari F; Vesal S; Hasheminia SJ; Dehghani L
    Iran J Immunol; 2014 Jun; 11(2):134-8. PubMed ID: 24975970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.